Want to see JBIO full AI Analyst Report?

Jade Biosciences (JBIO) Stock Forecast & Price Target

224 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

JBIO Analyst Ratings

Strong Buy

10 Buy

0 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Jade

Biosciences

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

JBIO Stock 12 Month Forecast

Average Price Target

$50.13

▲(149.63% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Jade Biosciences in the last 3 months. The average price target is $50.13 with a high forecast of $77.00 and a low forecast of $40.00. The average price target represents a 149.63% change from the last price of $20.08.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","78":"$78","23.25":"$23.3","41.5":"$41.5","59.75":"$59.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":77,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$77.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":50.125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$50.13</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,23.25,41.5,59.75,78],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.75,24.153846153846153,28.557692307692307,32.96153846153847,37.36538461538461,41.769230769230774,46.17307692307693,50.57692307692308,54.98076923076923,59.38461538461539,63.78846153846154,68.1923076923077,72.59615384615385,{"y":77,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.75,22.08653846153846,24.423076923076923,26.759615384615387,29.096153846153847,31.432692307692307,33.769230769230774,36.10576923076923,38.44230769230769,40.77884615384615,43.11538461538461,45.45192307692308,47.78846153846154,{"y":50.125,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.75,21.307692307692307,22.865384615384617,24.423076923076923,25.98076923076923,27.53846153846154,29.096153846153847,30.653846153846153,32.21153846153846,33.769230769230774,35.32692307692308,36.88461538461539,38.44230769230769,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.89,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.62,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.11,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.8,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.1,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.43,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.65,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.12,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.02,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.23,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.59,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.81,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.75,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$77.00

Average Price Target$50.13

Lowest Price Target$40.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Alex Thompson CFA

Stifel Nicolaus

$40

Buy

99.20%

Upside

Reiterated

08/13/26

Jade Biosciences (JBIO) Receives a Rating Update from a Top Analyst

Arthur He CFA

H.C. Wainwright

$55

Buy

173.90%

Upside

Reiterated

08/11/26

Analysts Are Bullish on Top Healthcare Stocks: Sana Biotechnology (SANA), Jade Biosciences (JBIO)

Laura Chico

Wedbush

$45→$47

Buy

134.06%

Upside

Reiterated

08/11/26

Jade Biosciences price target raised to $47 from $45 at WedbushJade Biosciences price target raised to $47 from $45 at Wedbush

Akash Tewari

Jefferies

$40→$48

Buy

139.04%

Upside

Reiterated

08/11/26

Jade Biosciences price target raised to $48 from $40 at JefferiesJade Biosciences price target raised to $48 from $40 at Jefferies

Tyler Van Buren

TD Cowen

―

Buy

―

Reiterated

08/10/26

Analysts Conflicted on These Healthcare Names: Jade Biosciences (NASDAQ: JBIO), MoonLake Immunotherapeutics (NASDAQ: MLTX) and Quanterix (NASDAQ: QTRX)

Julian Harrison

BTIG

$74→$77

Buy

283.47%

Upside

Reiterated

08/10/26

Analyst Julian Harrison Lifts Jade Biosciences Price Target to $77 and Reiterates Buy on Strong Pipeline and De-Risked IgA Program

Rami Katkhuda

LifeSci Capital

$42

Buy

109.16%

Upside

Reiterated

08/10/26

Jade Therapeutics: Buy Rating Reiterated as Strong Cash Position and Pipeline Progress Support Unchanged $42 Price Target

Vamil Divan

Guggenheim

$47

Buy

134.06%

Upside

Reiterated

08/10/26

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (NASDAQ: JBIO), Spyre Therapeutics (NASDAQ: SYRE) and Innate Pharma (NASDAQ: IPHA)

Matt Phipps

William Blair

―

Buy

―

Reiterated

08/10/26

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (NASDAQ: JBIO), Silence Therapeutics (NASDAQ: SLN) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Michael Yee

UBS

$45

Buy

124.10%

Upside

Initiated

06/15/26

Jade Biosciences initiated with a Buy at UBSJade Biosciences initiated with a Buy at UBS

Kaveri Pohlman

Clear Street

$25

Buy

24.50%

Upside

Reiterated

12/01/25

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (NASDAQ: JBIO) and Boston Scientific (NYSE: BSX)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Alex Thompson CFA

Stifel Nicolaus

$40

Buy

99.20%

Upside

Reiterated

08/13/26

Jade Biosciences (JBIO) Receives a Rating Update from a Top Analyst

Arthur He CFA

H.C. Wainwright

$55

Buy

173.90%

Upside

Reiterated

08/11/26

Analysts Are Bullish on Top Healthcare Stocks: Sana Biotechnology (SANA), Jade Biosciences (JBIO)

Laura Chico

Wedbush

$45→$47

Buy

134.06%

Upside

Reiterated

08/11/26

Jade Biosciences price target raised to $47 from $45 at WedbushJade Biosciences price target raised to $47 from $45 at Wedbush

Akash Tewari

Jefferies

$40→$48

Buy

139.04%

Upside

Reiterated

08/11/26

Jade Biosciences price target raised to $48 from $40 at JefferiesJade Biosciences price target raised to $48 from $40 at Jefferies

Tyler Van Buren

TD Cowen

―

Buy

―

Reiterated

08/10/26

Analysts Conflicted on These Healthcare Names: Jade Biosciences (NASDAQ: JBIO), MoonLake Immunotherapeutics (NASDAQ: MLTX) and Quanterix (NASDAQ: QTRX)

Julian Harrison

BTIG

$74→$77

Buy

283.47%

Upside

Reiterated

08/10/26

Analyst Julian Harrison Lifts Jade Biosciences Price Target to $77 and Reiterates Buy on Strong Pipeline and De-Risked IgA Program

Rami Katkhuda

LifeSci Capital

$42

Buy

109.16%

Upside

Reiterated

08/10/26

Jade Therapeutics: Buy Rating Reiterated as Strong Cash Position and Pipeline Progress Support Unchanged $42 Price Target

Vamil Divan

Guggenheim

$47

Buy

134.06%

Upside

Reiterated

08/10/26

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (NASDAQ: JBIO), Spyre Therapeutics (NASDAQ: SYRE) and Innate Pharma (NASDAQ: IPHA)

Matt Phipps

William Blair

―

Buy

―

Reiterated

08/10/26

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (NASDAQ: JBIO), Silence Therapeutics (NASDAQ: SLN) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Michael Yee

UBS

$45

Buy

124.10%

Upside

Initiated

06/15/26

Jade Biosciences initiated with a Buy at UBSJade Biosciences initiated with a Buy at UBS

Kaveri Pohlman

Clear Street

$25

Buy

24.50%

Upside

Reiterated

12/01/25

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (NASDAQ: JBIO) and Boston Scientific (NYSE: BSX)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Jade Biosciences

3 Months

Vamil DivanGuggenheim

Success Rate

5/7 ratings generated profit

Average Return

+3.44%

Copying Vamil Divan's trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +3.44% per trade.

1 Year

Tyler Van BurenTD Cowen

Success Rate

7/8 ratings generated profit

Average Return

+82.14%

Copying Tyler Van Buren's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +82.14% per trade.

2 Years

Tyler Van BurenTD Cowen

Success Rate

7/8 ratings generated profit

Average Return

+90.18%

Copying Tyler Van Buren's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +90.18% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

JBIO Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, JBIO has received 19 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. JBIO average Analyst price target in the past 3 months is 50.13.

Each month's total comprises the sum of three months' worth of ratings.

JBIO Financial Forecast

JBIO Earnings Forecast

Next quarter’s earnings estimate for JBIO is -$0.73 with a range of -$0.86 to -$0.57. The previous quarter’s EPS was -$0.76. JBIO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year JBIO has Performed in-line its overall industry.

No data currently available

JBIO Sales Forecast

Next quarter’s sales forecast for JBIO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. JBIO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year JBIO has Performed in-line its overall industry.

JBIO Stock Forecast FAQ

What is JBIO’s average 12-month price target, according to analysts?

Based on analyst ratings, Jade Biosciences, Inc.’s 12-month average price target is 50.13.

What is JBIO’s upside potential, based on the analysts’ average price target?

Jade Biosciences, Inc. has 149.63% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is JBIO a Buy, Sell or Hold?

Jade Biosciences, Inc. has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.

What is Jade Biosciences, Inc.’s price target?

The average price target for Jade Biosciences, Inc. is 50.13. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $77.00 ,the lowest forecast is $40.00. The average price target represents 149.63% Increase from the current price of $20.08.

What do analysts say about Jade Biosciences, Inc.?

Jade Biosciences, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of JBIO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Jade Biosciences (JBIO) Stock Forecast & Price Target

JBIO Analyst Ratings

JBIO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Jade Biosciences

JBIO Analyst Recommendation Trends

JBIO Financial Forecast

JBIO Earnings Forecast

JBIO Sales Forecast

JBIO Stock Forecast FAQ

Detailed List of Analyst Forecasts